INTRODUCTION
Most mammalian adult tissues harbor a subpopulation of tissuespecific stem and progenitor cells (hereafter referred together as stem cells) that differentiate into some or all of the parenchymal cells of their tissue of origin (Weissman, 2000) . Cardiac resident stem cells in embryonic, neonatal, and adult mammalian heart have been identified by different membrane markers (c-kit, Sca-1, Abcg-2, Flk-1, and PDGFR-a) and transcription factors (Isl-1, Nkx2.5, GATA4, and Wt-1) (Vincent and Buckingham, 2010; Torella et al., 2007; Chong et al., 2011; Smart et al., 2011) . It is likely that a number of these identified cell populations represent different developmental and/or physiological stages of a unique resident stem cell (Ellison et al., 2010) .
Intensive research on the adult mammalian heart's capacity for self-renewal has led to a consensus that new cardiomyocytes (hereinafter CMs) are indeed formed throughout adult mammalian life (Hsieh et al., 2007; Bergmann et al., 2009 ). However, the physiological significance of this renewal, the origin of the new CMs, and the rate of adult CM turnover are still highly debated. Whereas some recent studies have calculated a yearly CM turnover of about 1% (Bergmann et al., 2009) , others have calculated 4%-10% (Senyo et al., 2013) and some as high as 40% per year (Kajstura et al., 2012) . Similar discrepancy exists regarding the origin of the new CMs and their physiological significance. Myocyte replacement, particularly after injury, was originally attributed to differentiation of a stem cell compartment (Beltrami et al., 2003) , a source confirmed by genetic cell fate mapping (Hsieh et al., 2007) . More recently, it has been reported that CMs in the border zone of an infarct are replaced by the division of pre-existing postmitotic myocytes (Senyo et al., 2013) . These results would shift the target of regenerative therapy toward boosting mature CM cell-cycle re-entry. However, the experiments of Senyo et al. (2013) document that a very small fraction of CM DNA replication occurs in cells that have already activated the myosin heavy chain (MHC) gene, a well-known aspect of myocyte development; these data fall short of documenting mature myocyte re-entry into the cell cycle.
The adult endogenous c-kit pos CD45 neg tryptase neg cardiac stem cells (hereafter, c-kit pos eCSCs or just eCSCs) participate in adaptations to myocardial stress (Ellison et al., 2007a; Waring et al., 2012) , and, when transplanted into the myocardium, regenerate most cardiomyocytes and microvasculature lost in an infarct (Beltrami et al., 2003) . Recently, the in situ myogenic potential of adult c-kit pos cardiac cells has been questioned as being significantly reduced, particularly in comparison to their neonatal counterparts (Zaruba et al., 2010; Jesty et al., 2012) .
To revisit the regenerative potential of c-kit pos eCSCs, we employed experimental protocols of severe diffuse myocardial damage which, unlike an experimental infarct, spares the eCSCs (Ellison et al., 2007b) , in combination with several genetic murine models and cell transplantation approaches. Here, we demonstrated that eCSCs are necessary and sufficient for myocyte regeneration, leading to complete cellular, anatomical, and functional myocardial recovery.
RESULTS

Robust eCSC Activation and Myocyte Regeneration Follow Myocardial Damage in the Presence of a Patent Coronary Circulation
To follow c-kit pos eCSC physiological response to cardiac injury, we induced severe diffuse myocardial damage in adult rats with a single high dose of isoproterenol (ISO) (Ellison et al., 2007b) . New cell formation was monitored with bromodeoxyuridine (BrdU) labeling in vivo (Waring et al., 2012) . In the presence of a patent coronary circulation, ISO produces a Takotsubo-like cardiomyopathy (Akashi et al., 2008) with both diffuse subendocardial and apical CM death. This acute insult kills 8%-10% of the left ventricle (LV) CMs and results in overt acute heart failure (Ellison et al., 2007b) . Interestingly, the myocardial damage and heart failure spontaneously reverse anatomically and functionally by 28 days ( Figure S1 available online). Whereas in the normal myocardium (CTRL) most c-kit pos eCSCs are quiescent (>90% BrdU neg and Ki67 neg ), after ISO damage, a high fraction enters the cell cycle ( Figures 1A-1C and S1). At day 3, $88% are BrdU pos ( Figure 1C ), leading to an $8-fold increase in eCSC number, which decreases thereafter but remains above CTRL for up to 28 days ( Figure 1A) .
The expansion of the eCSC pool in response to CM loss by ISO damage was followed by their commitment to myocardial cell lineages. Indeed, many of the c-kit pos eCSCs expressed GATA4
( Figure S1 ) and Nkx2.5 ( Figures 1D and 1E ), two early transcription factors of the cardiac lineage which, together with Tbx5 and MEF-2C, are essential for the differentiation of mesoderm and reprogramming of fibroblasts into the CM lineage (Takeuchi and Bruneau, 2009; Qian et al., 2012; Song et al., 2012) . Figures 1E and S1 ). This sequential transition from undifferentiated cells to committed progeny is further illustrated by the transcription of sarcomeric and gap junction genes (troponin I, cTnI; connexin 43, Cnx43) and the presence of their corresponding proteins, even though at lower levels than found in the adult spared CMs ( Figures 1D and S1 ). These new c-kit pos GATA-4 posNkx2.5 pos myogenic progenitors express b-MHC, the isoform characteristic of the fetal rat heart (Lompré et al., 1984) . No expression of the a-Mhc gene, characteristic of adult rat CMs and expressed by spared CMs 72 hr after ISO, was detected ( Figure S1 ). Starting at day 3 post-ISO, very small mononucleated BrdU pos
Ki67
pos CMs, including some in mitosis, were detected ( Figures 1F-1L ), which is indicative of immature, proliferative CMs. These new CMs were localized mainly in the LV subendocardium and apex, the area most severely damaged by ISO. From 3 to 28 days, there was a significant increase in the number ( Figures 1H and 1I ) and size of these CMs, which were nearly all mononucleated and smaller than the spared (BrdU neg ) ones (Figure 1L) . The BrdU pos CMs also expressed CNX43, suggestive of gap junction formation and integration with the neighboring myocardium ( Figure 1J ). Rod-shaped small BrdU pos CMs were also detected as single cells when isolated from ISO-treated hearts ( Figure 1K ). Their smaller size indicates that, despite the normal histology and function of the ISO-treated hearts 4 weeks postinjury, the newly regenerated CMs had not yet fully matured.
Myocyte Regeneration after Diffuse Myocardial Damage
Is Not the Product of Pre-existing Myocyte Division or Bone Marrow Cells BrdU labeling and Ki67 expression cannot establish whether the new CMs are generated by the reported division of pre-existing All data are mean ± SD. See also Figure S1 .
Cell 154, 827-842, August 15, 2013 ª2013 Elsevier Inc. 829 (legend continued on next page) adult CMs or by the activation and ensuing differentiation of a stem cell compartment. To specifically address this issue, we traced the cell lineage of the new CMs. We generated doubletransgenic mice (MerCreMer-ZEG) (Hsieh et al., 2007; Loffredo et al., 2011) in which, upon tamoxifen administration, b-galactosidase (b-gal) is replaced by enhanced GFP exclusively in cardiac cells that have already activated the Myh6 gene (and, therefore, the transgene carrying the cre recombinase gene), which are either postmitotic CMs or amplifying cells already committed to the CM lineage (i.e., immature myocytes/myocyte precursors).
In tamoxifen-naive MerCreMer-ZEG mice, 99 ± 0.2% of the CMs express b-gal and are negative for GFP (the leakage of the Myh6-Cre construct in these animals is $0.2%). Tamoxifen correctly switched b-gal to GFP in CMs (Figures 2A-2C ). This resulted in hearts composed of 83 ± 3% GFP pos and 17 ± 2% b-gal pos CMs ( Figures 2B and 2C ), as previously reported (Hsieh et al., 2007; Senyo et al., 2013 Figure 2A ). In mice, ISO injection caused the same type of myocardial damage and LV dysfunction shown in rats, resulting in c-kit pos eCSC activation, CM regeneration, and recovery of cardiac function ( Figure S2 ). When ISO was administered to CM-recombined MerCreMer/ZEG mice ( Figure 2A ) followed by BrdU labeling, 28 days later there was a significant increase in the percentage of b-gal pos CMs: 18% ± 2.5% in saline-treated mice versus 26.5 ± 2% in ISO-injured mice ( Figures 2B and 2C ), accompanied by a decrease of GFP pos CMs in the hearts of ISO-treated mice (73.5 ± 3.5%) compared to CTRL mice (82 ± 3.5%) ( Figures  2B and 2C ). There was also a concomitant increase of BrdU pos CMs (9 ± 2%) in the ISO-treated hearts, and these were b-gal pos ( Figures 2D and 2E ). These numbers match the CM loss produced by ISO administration ( Figure S2 ). In contrast, we detected very few newly generated BrdU pos b-gal pos CMs (0.15 ± 0.05%) in saline-treated CTRL mice ( Figure 2E ). This result concurs with Hsieh et al. (2007) but disagrees with the interpretation of Senyo et al. (2013) using the same genetic tools. This discrepancy might be due to the different injury models used. In contrast to coronary ligation, ISO kills a large number of CMs in the presence of patent coronary circulation, and it spares the eCSCs. Thus, ISO provides a more physiologic test for the endogenous reparative potential of the adult heart (Ellison et al., 2007b) . Furthermore, during the 2 week administration of tamoxifen for Cre induction, it would be expected that some eCSCs have committed to the myogenic lineage and activated the Myh6 gene with recombination of the transgene and generation of b-gal pos CMs, as reported by Dong et al. (2012) .
Although cell fusion might allow the expression of both GFP and b-gal in the same CM, it can be ruled out because the percentage of CMs positive for both markers was negligible (<0.1%) in saline-treated CTRL and ISO-injured mice. The possibility that the decrease in GFP pos and corresponding increase in b-gal pos CMs after ISO might be due to a higher susceptibility of GFP-labeled CMs to ISO damage was also excluded by the fact that the percentage of necrotic and apoptotic GFP pos and b-gal pos CMs 1 day after ISO was similar ( Figure S2 ). Finally, we dissociated to single cells CMs from the hearts of double-transgenic MerCreMer:RYP mice obtained by crossing MerCreMer with R26R-EYFP (RYP) mice (Qian et al., 2012) , in which the CMs were labeled with the enhanced yellow fluorescent protein (EYFP) upon tamoxifen injection. In agreement with the data shown on MerCreMer:ZEG mice, tamoxifen-driven induction of YFP marked $80% of endogenous CMs in the uninjured CTRL heart, which decreased to $72% in the apex (and subendocardium) of injured hearts at 28 days after ISO. Only the YFP neg fraction isolated from the CM-recombined double-transgenic mice was BrdU pos ( Figure 2F ). Most of these newly generated BrdU pos YFP neg CMs were rod shaped, mononucleated, and smaller than the pre-existing (mostly binucleated) YFP pos BrdU neg CMs ( Figure 2F ).
In conclusion, after diffuse myocardial injury, new CMs are not generated (at least in quantities above background) through the division of pre-existing terminally differentiated CMs as claimed (Senyo et al., 2013) but rather are generated from non-CM cells with the characteristics of a stem compartment (Hsieh et al., 2007) .
Bone marrow (BM)-derived cells have been implicated in cardiac regeneration after myocardial infarction (Orlic et al., 2001; Loffredo et al., 2011) . To test this possibility, either saline or ISO was injected to sublethally g-irradiated mice 3 months after successful reconstitution of their BM with BM cells from Tg GFP mice (Sata et al., 2002) . In both CTRL and ISO-treated animals, a small fraction (3.5 ± 2% versus 5 ± 2%, respectively) of c-kit pos CD45 neg cardiac cells was GFP positive at 28 days ( Figure 2G ). However, despite extensive histological analysis and CM isolation, we were unable to find a single BM-derived GFP (I) CM regeneration after BM GFP transplantation. *p < 0.05 versus CTRL.
All data are mean ± SD. See also Figure S2 . (legend continued on next page) subset of adult resident c-kit pos eCSCs and their myocyte committed progeny ( Figure 3A ). We generated a lentivirus carrying Cre-recombinase under the control of the c-kit promoter (Lenti-c-kit/Cre) with a pattern of expression restricted to c-kit pos cells ( Figure S3 ; Cairns et al., 2003) . To confine lentivirus release to the LV myocardium, we employed a fibrin-based PEGylated hydrogel for epicardial delivery (Zhang et al., 2006) . To increase delivery, we also injected the lentivirus directly into the apex, the region with the greatest CM damage after ISO (Ellison et al., 2007b) and with the highest concentration of c-kit pos eCSCs (Ellison et al., 2011) . This combined strategy was used to selectively release Lenti-c-kit/Cre into the myocardium of RYP reporter mice ( Figure 3A) . In these mice, the uptake of the c-kit/Cre recombinase lentivirus by any c-kit pos cell deletes the STOP sequence in the transgene and switches on the expression of EYFP. After 2 weeks, peripheral blood cells and BM-derived cells were reproducibly negative for EYFP (Figure S3) . Importantly, 38 ± 5% of total and 65 ± 7% of apexconfined c-kit pos eCSCs were EYFP positive ( Figures 3B-3D ).
Lenti-c-kit/Cre injection induced EYFP expression exclusively in cardiac c-kit pos cells, whereas CMs ( Figure 3C ) and other c-kit neg myocardial cell types were all negative for EYFP (Figure S3) . When the recombined EYFP pos c-kit pos CD45 neg eCSCs were isolated from the hearts of RYP mice at 2 weeks after lentivirus release, they were phenotypically indistinguishable from the unrecombined EYFP neg -c-kit pos CD45 neg eCSCs and exhibited the typical properties of resident eCSCs, being clonogenic, self-renewing, and multipotent ( Figure S3 ). 14 days after local release of the Lenti-c-kit/Cre, RYP mice received either ISO or saline (CTRL) injection. 28 days after ISO, we confirmed that there were no recombined EYFP-positive cells in the c-kit pos -enriched fraction of the nucleated cells of peripheral blood or within the BM from CTRL and ISO-injured mice ( Figure S3 ). In CTRL mice, after 4 weeks of BrdU in vivo labeling, a total of 0.18 ± 0.07% BrdU pos CMs was detected, and only a fraction of those newly generated cells were c-kit pos eCSC-derived EYFP pos BrdU pos CMs (0.06 ± 0.02%/total CMs) ( Figure 3E ). In the ISO-treated hearts, a significant fraction of a total 9.5 ± 2% of newly formed CMs were EYFP positive (43 ± 3% of total BrdU pos CMs, which, in the apex, reached 74 ± 7%) ( Figures 3E and 3F ), indicating that these newly generated CMs are the progeny of the c-kit pos eCSCs. We confirmed the identity of both YFP pos -and YFP neg -BrdU pos CMs in isolated CMs 28 days after ISO ( Figure 3G ) by fluorescence-activated cell sorting (FACS). YFP expression was analyzed in unfixed CMs to avoid fluorescent protein leakage, as well as fixative-induced autofluorescence. FACS detected >98% cTnI-positive cells in the fixed aliquot of the CM preparation in both CTRL and ISO groups ( Figure 3H ). <0.5% of YFP pos cells were detected in the unfixed aliquot of the same CM preparation from CTRL c-kit/ Cre recombined RYP mice ( Figure 3H ). Thus, it was technically impossible to ascertain by FACS whether they were truly c-kit pos eCSC-derived CMs. More significantly, YFP pos cells were clearly recognized within the unfixed CM preparation from ISO-injured hearts (2.9 ± 0.5% in total LV and 8.3 ± 1% in LV apex) (Figure 3H) . We further verified that the YFP signal truly originated from YFP pos CMs by sorting the total CM preparation and demonstrating that R99% were aSA positive after cell fixation ( Figure S4 ). These results were not due to c-kit re-expression in adult CMs, as suggested previously in cryo-injured hearts (Tallini et al., 2009 ). The absence of such re-expression in salineor ISO-treated transgenic mice expressing GFP under the c-kit promoter ( Figure S4 ) rules out this potential confounding factor. To further test the identity and the degree of differentiation of the newly regenerated eCSC-derived CMs, we obtained Table S1 ). The eCSC-derived YFP pos CMs expressed the main CM transcription factors, as well as sarcomeric contractile genes, but still maintained the expression of cell-cyclerelated and high-metabolic-state genes typical of immature (neonatal) not yet terminally differentiated CMs (Figures 3I and  3J) . Intriguingly, even after having acquired mature sarcomeric structures and a rod shape ( Figure 3G ), eCSC-derived YFP pos CMs show an incomplete switch from retinoblastoma-like 1 (Rbl-1 or p107) to retinoblastoma protein (Rb), which is a requirement for permanent CM withdrawal from the cell cycle (Schneider et al., 1994) . These data further demonstrate that resident c-kit pos eCSCs generate new CMs in vivo that are still immature 4 weeks after their birth. Taken together, these in vivo genetic cell-fate-mapping experiments show that c-kit pos eCSCs have intrinsic cardiac regenerative potential, replacing lost CMs lost after diffuse myocardial injury. Figure 4A ) were injected through the tail vein of rats 12 hr after ISO injury. As cell control, ISO-injured rats were injected with 5 3 10 5 GFPtagged c-kit negative sorted CM-depleted cardiac cells (c-kitneg MDCCs GFP ; containing 86 ± 5% cardiac fibroblasts, 13 ± 3% vascular smooth muscle, 1 ± 1% endothelial and <0.001% c-kit pos cardiac cells). To control for the role of injury in the (I) Heatmap showing two-way hierarchical cluster of the expression of 3,774 genes that underwent a log fold change R 1 or % À1 (p < 0.005). See also Table S2 ). In contrast, in ISO-injured hearts, there was very efficient cardiac homing and engrafting of the transplanted CSCs GFP , which accounted for most of the injected cells ( Figures 4B, 4E , and 4F) ( Table S2 ). The high cardiac tropism and engrafting efficiency of the cloned CSCs GFP compared to the extra-cardiac tissues is shown in Table S2 and Figure S5 . Of the myocardial-homed CSCs GFP , 55 ± 5%, 20 ± 4%, and 8 ± 3% were Ki67 pos at 1, 6, and 28 days posttransplantation, respectively ( Figure 4G ). There was also an increase in GFP pos cells expressing a-sarcomeric actin at 6 (25 ± 3%) and 28 (42 ± 3%) days. At 28 days, CSC GFP -derived newly formed GFP pos CMs (4 ± 1%; Figure 4H ) had well-developed sarcomeres and were larger and more differentiated (diameter of 10 ± 2mm) but were still smaller than normal adult fully differentiated GFP neg CMs (diameter of 14 ± 1mm; p < 0.01 versus GFP pos CMs). We further quantified the number of transplanted c-kit pos CSC-derived GFP pos CMs by FACS, which was in agreement with the immunohistochemistry data ( Figure S5 ). At 28 days after ISO and CSC GFP tail-vein injection, of the total GFP pos cardiac cells, the majority became CMs (64 ± 4%) but also became smooth muscle (10 ± 3%) and endothelial (14 ± 3%) vascular cells and fibroblasts, whereas few of them stayed as c-kit pos CSCs (Table S3 ).
To further ascertain that the tail-vein-injected cells generated bona fide CMs, c-kit pos eCSCs expressing GFP under the control of the cardiac troponin I (cTnI) promoter were tail injected after ISO as above. At 28 days, a population of CSC-derived cTnI pos GFP pos CMs was detected ( Figure S5 ). Because the SDF-1-CXCR4 axis is involved in retention and mobilization of stem cells in the adult (Askari et al., 2003) , we evaluated whether this receptor-ligand pair homes CSCs GFP to ISO-injured myocardium. SDF-1 is rapidly upregulated in CMs after ISO damage ( Figures 4I and S5 ). 5 310 5 -c-kit pos eCSCs genetically modified to knock down expression of the SDF-1 receptor with a lentiviral vector carrying a CXCR4 shRNA tagged with GFP (CXCR4 KD CSCs GFP ; Figure S5 ) were tail-vein injected into rats 12 hr after ISO injury. The CXCR4 KD CSCs GFP did not show any cardiac tropism, as most were lodged in the spleen and lungs ( Figure 4J and Table S4 ). Concurrently, tail-veininjected CSCs GFP also failed to home to the myocardium of ISO-injured rats treated with an anti-SDF-1 neutralizing antibody 20 min before and 12 hr after cell injection ( Figure 4K ). These results show that the c-kit pos CSCs have a strong tropism for the damaged myocardium, which is CXCR4-SDF-1 dependent and is where the enhanced expression of SDF-1 by the surviving myocardium serves as a positive chemotactic agent. ). This regime (ISO+5-FU) ablated eCSC expansion and new CM formation ( Figures 5A-5C ), resulting in a severe cardiomyopathy (ISO+5-FU induced) ( Figure 5D ) with a deficit and significant hypertrophy of the spared CMs, as compared to animals treated with ISO alone (ISO+saline), in which regeneration was normal ( Figure S6 ). Although all ISO+saline animals survived the acute myocardial insult and fully recovered cardiac function, the ISO+5-FU animals developed heart failure ( Figures 5D and S6 ) with increased mortality (4 of 10 ISO+5-FU-treated animals versus 0 of 10 for the ISO+ saline animals) at 28 days. These effects were not due to 5-FU toxicity because the same 5-FU regime administered to control animals did not cause any cellular or functional cardiac or extracardiac toxic effects, including in the bone marrow ( Figure S6 ). However, 5-FU would have targeted other replicating cells together with activated eCSCs. Indeed, at 3 days after ISO when 5-FU started to be administered, the eCSCs represented only 17 ± 3% of total Ki67-positive myocardial cells, whereas 55 ± 4% were inflammatory cells (i.e. granulocytes and macrophages). A small fraction was cycling cardiac fibroblasts (9 ± 2%), smooth muscle (4 ± 1%), and endothelial (5 ± 2%) cells.
To evaluate the effect, if any, of ablating non-eCSCs on blocking the regenerative response and simultaneously to establish a causal relationship between eCSC activation on one hand and myocardial regeneration and repair on the other, we injected 5 3 10 5 cloned CSCs GFP or the same number of GFP pos cardiac fibroblasts (cFibro) into the tail vein of rats with ISO+5-FU cardiomyopathy 28 days after ISO. Additionally, to address whether the transplanted cells and their progeny are continuously required to maintain cardiac cell homeostasis and functional recovery, in a separate set of animals, we transplanted cells from an eCSC clone expressing GFP together with the herpes simplex virus thymidine kinase (CSC GFP/TK ). Ganciclovir (GCV) administration produces selective suicide of the transplanted CSC GFP/TK and their progeny ( Figure S7 ). As an additional control, saline was tail-vein injected into another group of animals. See Figure 6A for the study design. At 2 months, the surviving rats with ISO+5-FU cardiomyopathy that received either saline or cFibro were indistinguishable and in overt heart failure with a dramatic deficit in c-kit pos eCSCs, a lack of CM regeneration, and increased CM death and hypertrophy ( Figures 6B, 6D , and S7). In contrast, 95% of the animals treated with CSCs GFP were alive at 2 months, showing efficient homing and nesting of CSCs GFP into the damaged myocardium, which had reconstituted the resident eCSC pool ($90% cell (G and H) Confocal microscopy of c-kit pos CSCs GFP -derived CMs in situ and following isolation at 3 months after tail-vein injection. Scale bar, 20 mm.
All data are mean ± SD. See also Figures S7 and S8 and Table S5. chimerism; Figures 6D, 6F , and S7). These CSC GFP chimeric hearts had complete restoration of ventricular volumes and function ( Figures 6B, 6C , and S7 and Table S5 ) with $8% GFP pos CMs ( Figure 6D ), indicating that they are the progeny of the transplanted cells. These data, in addition to highlighting the homing and regenerative capacity of the CSCs, also point to these cells as one of the cell targets of the in vivo direct reprogramming protocols for myocardial regeneration using retroviral vectors encoding CM-determining genes (Qian et al., 2012; Song et al., 2012) .
To rule out that cell fusion was the source of the new GFP Table S5 ). At 56 days ($2 months), additional animals with ISO+5-FU cardiomyopathy rescued by exogenous CSCs GFP or CSCs GFP/TK were treated with either saline or GCV for 2 weeks and sacrificed at 84 days ($3 months). At this time point, CSCs GFP and CSCs GFP/TK rats treated with saline showed a fully reconstituted eCSC pool together with myocardial regeneration and repair (Figures 6D, 6G, and S7) . Myocardial immunohistochemistry was corroborated at the single-cell level, quantifying isolated rod-shaped GFP pos CMs by immunocytochemistry and FACS (Figures 6H and S8) . CSC-derived GFP pos CMs were still mostly mononucleated but had a size comparable to pre-existing CMs, indicating that the maturation of newly generated CMs is completed in 2 months ( Figures 6G and S8) . Furthermore, CSC GFP -derived CMs expressed cardiac transcription factors and contractile genes with mRNA levels comparable with normal adult CMs ( Figure S8 ).
GCV treatment did not cause any histological or functional adverse effects to the rats in the ISO+5-FU+CSC GFP group.
In contrast, GCV treatment of ISO+5-FU+CSCs GFP/TK group activated the programmed suicide of CSCs GFP/TK and their progeny, which caused a dramatic reversal of all the recovered cellular and functional parameters ( Figures 6D and S7) . At 3 months, the myocardium was devoid of CSCs GFP/TK and of GFP pos CM progeny ( Figure 6D ), which was accompanied by pathologic remodeling, ventricular chamber dilation, and hemodynamic deterioration to levels of overt cardiac failure (Figure 6D and Table S5 ). Finally, the reported ''bystander effect'' of GCV (Yoon et al., 2010) was ruled out by several lines of evidence. First, GCV at a concentration sufficient to kill the CSCs GFP/TK cultured with adult rat ventricular CMs in a 10:1 ratio does not affect survival of the latter ( Figure S8) (Figure 7 ). They were clonogenic, self-renewing, formed typical cardiospheres, and differentiated into CMs, endothelial, and smooth-muscle cells in vitro ( Figures 7A-7J) . A clone of the reisolated c-kit pos CSC GFP , when transplanted back into rats with ISO+5FU cardiomyopathy, proved indistinguishable from the primary parental clone in their efficiency to replenish the depleted eCSC and CM-pool and reverse the severe cardiac dysfunction ( Figure S9 ). Furthermore, when these reisolated cells were transplanted into rats with acute myocardial infarction, they repopulated the ischemic myocardium with new GFP pos CMs and vascular cells, leading to improved LV function ( Figures 7K-7Q ).
DISCUSSION
The results presented here demonstrate that c-kit pos eCSCs behave as true resident, endogenous stem cells, which are necessary and sufficient for myocardial repair and cellular homeostasis. These results, however, do not rule out the participation of other cardiac stem-cell-like populations (Oh et al., 2003; Chong et al., 2011; Smart et al., 2011) or minor contributions by other cells (Senyo et al., 2013) . Because the c-kit/cre lentivirus strategy labeled approximately half of the c-kit pos eCSCs in the LV (Figure 3) , these results cannot determine whether the fraction of newly generated EYFP neg CMs was not labeled because of the lentivirus inefficiency in vivo or because some of them are the progeny of c-kit neg stem and progenitor cells. Nonetheless, the replacement of the eCSC cohort by the progeny of a single CSC convincingly favors the first alternative.
It is generally accepted that, in healthy adult tissue, most stem cells are quiescent and if they cycle they do so very slowly, providing just enough transient amplifying cells to maintain tissue homeostasis (Orford and Scadden, 2008) . In contrast, the quiescent stem cells in response to injury are rapidly activated, multiply, and differentiate to replace the cells lost. In the healthy adult myocardium, >90% of the c-kit pos eCSCs are quiescent (G0) (Figure 1 ). In response to diffuse ISO injury, most eCSCs enter the cell cycle, replicate, and commit to the myocardial cell lineages (Figure 1 ), including CMs (Figure 3 ). Once the ISO-induced cell loss and cardiac failure have been corrected by the regenerated cells, the number of activated eCSCs diminishes progressively with a concomitant increase of the quiescent cohort (Figure 1) . Thus, the return to myocardial homeostasis is accompanied by the return of activated eCSCs to their quiescent state. This roundtrip from dormancy to activation and back to quiescence has been suggested for other self-renewing organs (Wilson et al., 2008) . This toggling between eCSC cycling states might just highlight the important role of these cells in the homeostasis of a tissue essential for organismic survival. Understanding the mechanisms by which cycling eCSCs return to quiescence has clinical implications to exploit the regenerative potential of these cells. The efficiency of some adult stem cells, such as HSCs and eCSCs, to specifically home to and nest into their tissue of origin is dependent on tissue damage together with depletion of the resident stem cells. This is so because the number of tissue niches appears to be limited and nonexpandable (Czechowicz et al., 2007) . Here, we show that the injured myocardium provides a milieu that supports the homing, nesting, survival, and differentiation of the CSCs (Figure 4) . However, if after injury the eCSCs are left in the tissue, despite the very effective cardiac homing of the transplanted CSC GFP , only a very small number succeed in long-term nesting in the myocardium. This behavior contrasts with a host myocardium that has been depleted of most eCSCs prior to transplantation (Figures 5 and 6 ). Then the empty niches are very efficiently occupied by the CSCs GFP transplanted through the systemic circulation, which not only survive but differentiate into the four main myocardial cell types and reconstitute the resident eCSC pool (Figure 6 ). The sturdiness of the CSC homing, engraftment, and regenerative properties after many passages in culture and cloning ( Figure 7 ) contrasts with the reported loss of engraftment of ex-vivo-expanded HSCs (Guenechea et al., 1999) and skeletal muscle satellite cells (Montarras et al., 2005) . Therefore, this robust homing of the eCSCs could be exploited to replace the stem cell population of the myocardium by noninvasive means, as clinically implemented now for the bone marrow.
The HSCs are the best-understood adult stem cells and have become the standard for most adult stem cell biology. Unfortunately, solid tissues have serious experimental limitations over the bone marrow, in which it is possible to transplant a single genetically tagged HSC and follow its progeny in the host (Rossi et al., 2008) . That no such feat is possible in solid tissues has hampered most attempts to define the role of tissue-specific stem cells in the regenerative process. So far there is no report of replacing the ablated stem cells with genetically tagged exogenous cells in solid tissues. Such replacement is required to produce a chimeric tissue whose regeneration can be shown to be dependent on the transplanted cells. In the myocardium, the best approximation to the HSC paradigm is transplantation of the progeny of a single cell. The high degree of cell chimerism obtained by transplantation of cloned CSCs GFP and CSC TK/GFP shows that the progeny of a single CSC can reconstitute the 5-FU ablated eCSC cohort and generate a cell chimeric heart with new cardiomyocytes and vascular cells, thereby restoring cardiac function. That the cellular and functional regeneration of the ISO-damaged myocardium is due to the transplanted CSCs is clearly shown by the rapid deterioration of cardiac function when these cells and their progeny are selectively killed by the GCV (Figure 6 ). The data presented here support the conclusion that the eCSCs are necessary and sufficient for anatomical and functional regeneration of the adult mammalian myocardium.
EXPERIMENTAL PROCEDURES Animals
Diffuse myocardial damage was induced by a single injection (s.c.) of ISO to rats (5 mg kg À1 ) or mice (200 mg kg À1 ). To ablate cycling cells, including eCSCs, after ISO-damage, 5-FU (Sigma) was administered (10 mg kg À1 )
for four cycles of 5 days each, starting at the third day post-ISO injection. Mer-CreMer mice were kindly provided by Drs. Tammie Bishop and Ludwig Thierfelder. ZEG and RYP mice were purchased at Jackson Laboratory. GCV was administered (i.p.) at the dose of 50 mg kg À1 twice daily for 14 days.
Lenti c-kit/cre
The c-kit/cre construct was generated starting from a construct encoding the EGFP gene under the c-kit promoter (Cairns et al., 2003) by replacing EGFP with the CRE gene.
Statistical Analysis
Data are reported as mean ± SD. Significance was determined by ANOVA. The Bonferroni post hoc method was used to locate the differences. Significance was set at p < 0.05.
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